Scholarlink

Background <p>E-cadherin-negative breast lymphoepithelial-like carcinoma (E-Cad-neg BLEC) is a rare malignant tumor. To date, no study has compared the clinicopathological characteristics and prognosis between E-Cad-neg BLEC and E-Cad-neg invasive lobular carcinoma (ILC).</p> Methods <p>To clarify the relationship between E-Cad-neg BLEC and E-Cad-neg ILC, we analyzed 12 patients with E-Cad-neg BLEC, comparing their clinicopathological characteristics and tumor prognosis with those of 578 patients with E-Cad-neg classical invasive lobular carcinoma (c-ILC) or 43 patients with E-Cad-neg pleomorphic lobular carcinoma (PLC).</p> Results <p>The results showed that E-Cad-neg BLEC was a diffuse, non-adherent tumor with pleomorphic growth. There was abundant lymphocyte infiltration in the tumor stroma. Lobular carcinoma in situ was observed around the tumor in 5 patients. Compared with E-Cad-neg c-ILC, E-Cad-neg BLEC had significantly lower expression levels of ER (<i>p</i> &lt; 0.001), PR (<i>p</i> &lt; 0.001), and HER2 (<i>p</i> = 0.029), and a higher Ki-67 proliferation index (<i>p</i> &lt; 0.001). Compared with E-Cad-neg PLC, E-Cad-neg BLEC was less likely to exhibit vascular invasion (<i>p</i> &lt; 0.001) and perineural invasion (<i>p</i> &lt; 0.001), and had lower HER2 expression (<i>p</i> = 0.001). In terms of histo-molecular subtypes, E-Cad-neg BLEC was mainly triple-negative, while E-Cad-neg c-ILC and E-Cad-neg PLC were mainly luminal A and luminal B. Regarding prognosis, the prognosis curve of E-Cad-neg BLEC was close to that of E-Cad-neg c-ILC. Analysis of the percentage of tumor-infiltrating lymphocytes (TILs) revealed that in both E-Cad-neg c-ILC and E-Cad-neg PLC, higher TIL levels were associated with a poor prognosis, in contrast to the favorable prognosis observed in E-Cad-neg BLEC.</p> Conclusions <p>Our findings indicate that E-Cad-neg BLEC is a type of breast carcinoma characterized by extensive lymphocytic infiltration and high proliferative activity and is associated with a relatively favorable prognosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comparative analysis of clinicopathological characteristics and prognosis between E-cadherin-negative breast lymphoepithelioma-like carcinoma and E-cadherin-negative invasive lobular carcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月23日

查看全文
  • Rui Gao,
  • Xi Zhang,
  • Ying Lin,
  • Jie Lin,
  • Yihui He,
  • Lan Lin,
  • Ran Peng,
  • Xin Chen

摘要

Background

E-cadherin-negative breast lymphoepithelial-like carcinoma (E-Cad-neg BLEC) is a rare malignant tumor. To date, no study has compared the clinicopathological characteristics and prognosis between E-Cad-neg BLEC and E-Cad-neg invasive lobular carcinoma (ILC).

Methods

To clarify the relationship between E-Cad-neg BLEC and E-Cad-neg ILC, we analyzed 12 patients with E-Cad-neg BLEC, comparing their clinicopathological characteristics and tumor prognosis with those of 578 patients with E-Cad-neg classical invasive lobular carcinoma (c-ILC) or 43 patients with E-Cad-neg pleomorphic lobular carcinoma (PLC).

Results

The results showed that E-Cad-neg BLEC was a diffuse, non-adherent tumor with pleomorphic growth. There was abundant lymphocyte infiltration in the tumor stroma. Lobular carcinoma in situ was observed around the tumor in 5 patients. Compared with E-Cad-neg c-ILC, E-Cad-neg BLEC had significantly lower expression levels of ER (p < 0.001), PR (p < 0.001), and HER2 (p = 0.029), and a higher Ki-67 proliferation index (p < 0.001). Compared with E-Cad-neg PLC, E-Cad-neg BLEC was less likely to exhibit vascular invasion (p < 0.001) and perineural invasion (p < 0.001), and had lower HER2 expression (p = 0.001). In terms of histo-molecular subtypes, E-Cad-neg BLEC was mainly triple-negative, while E-Cad-neg c-ILC and E-Cad-neg PLC were mainly luminal A and luminal B. Regarding prognosis, the prognosis curve of E-Cad-neg BLEC was close to that of E-Cad-neg c-ILC. Analysis of the percentage of tumor-infiltrating lymphocytes (TILs) revealed that in both E-Cad-neg c-ILC and E-Cad-neg PLC, higher TIL levels were associated with a poor prognosis, in contrast to the favorable prognosis observed in E-Cad-neg BLEC.

Conclusions

Our findings indicate that E-Cad-neg BLEC is a type of breast carcinoma characterized by extensive lymphocytic infiltration and high proliferative activity and is associated with a relatively favorable prognosis.